What does the future hold for Halozyme Therapeutics Inc. (HALO) Stock?
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
Halozyme Therapeutics Inc. (NASDAQ:HALO) Stock is trading Higher 5.64% From 200-Day SMA
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
Halozyme Therapeutics Inc. (HALO) Stock is the one stock you should own forever
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
If you still want to check out Halozyme Therapeutics Inc. (HALO) Stock, you should do so again
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
Halozyme Therapeutics Inc. (NASDAQ:HALO) Stock Reported EPS of $0.82 in Last Quarter
H.C. Wainwright raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “a Buy”. The rating was released on July 24, 2023, according to finviz. We previously noted in another research note published on July 24, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target […]
Hold on to your shares: Halozyme Therapeutics Inc. (HALO) Stock
H.C. Wainwright raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “a Buy”. The rating was released on July 24, 2023, according to finviz. We previously noted in another research note published on July 24, 2023 by Goldman that downgraded the stock from a Buy to a Neutral with a price target […]
Is Halozyme Therapeutics Inc. (HALO) Stock A Better Investment Than Its Rivals?
H.C. Wainwright raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “a Buy”. The rating was released on July 24, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]
Halozyme Therapeutics Inc. (HALO) Stock: Thought Concerns
H.C. Wainwright raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “a Buy”. The rating was released on July 24, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]